article thumbnail

Digital Documentation: How PDFs Can Help Providers Expedite Care

HIT Consultant

The transition toward more digital recordkeeping in healthcare began in earnest in 2009 with the passage of the American Recovery and Reinvestment Act. If this documentation is primarily paper-based, researchers could have a difficult time ensuring each piece of documentation meets FDA standards.

FDA 98
article thumbnail

Health Provider News

Hall Render

in 256-Slice CT scanner Lifepoint reports $200M+ economic impact in Cen Ky St. in 256-Slice CT scanner Lifepoint reports $200M+ economic impact in Cen Ky St. Elizabeth Healthcare to open doors of new Cancer Center-Dearborn in Southeastern Indiana St. MASSACHUSETTS High demand is pushing hospitals past their limits, say Southeastern Mass.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

Ron DeSantis signs bills to train, retain healthcare workers Tampa health care REIT pays $86M for Texas, Arizona portfolio GEORGIA 9 Georgia hospitals earn awards for patient safety Another inmate escapes Grady Memorial Hospital CHI Memorial breaks ground on new North Georgia hospital CON overhaul gains final passage in General Assembly Ga.

article thumbnail

TwIqbal And Punitive Damages

Drug & Device Law

These allegations lack any contention or inference that [defendant] withheld or misrepresented information to the FDA. . ., 662 (2009). It does not give him license to evade the less rigid ? The ruling in question was that the TwIqbal ( Bell Atlantic Corp. Twombly , 550 U.S. 544 (2007), and Ashcroft v. Iqbal , 556 U.S.

Fraud 59
article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

But in prescription medical product liability litigation, products must receive FDA approval, clearance or other authorization (hereafter, collectively referred to as “approval” for short) before they can be marketed. Are manufacturers liable only for failing to employ an alternative design that the FDA has approved for distribution. . .

FDA 59